Vor Biopharma (VOR)

• Market cap: $128M
• 1 day: -1.42%
• 5 days: -22.6%
• 1 month: -44.67%
• 3 months: -54.83%
• 6 months: 74.6%
• Year to date: -16.52%
• 1 year: 12.11%
• 5 years: -97.51%
• 10 years: -97.51%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Employees: 168